Ansel changed its name from Brella Insurance this year. Its new name translates to “protector” in German, alluding to the company’s commitment of shielding its members from financial implications of medical events.
An insurtech has raised $20 million through a funding round led by VC group Portage.
Ansel, a company that offers simplified supplemental insurance for members diagnosed with more than 13,000 conditions, has now raised more than $50 million in total, according to a press release. The company's mission is to enhance, but not coordinate with, primary health insurance to help individuals with rising medical bills. Ansel was previously known as Brella Insurance.
The company will use the latest investments to scale its insurance offerings to employees across the country, including the 11 states Ansel is not yet available.
“Since launching Ansel in 2019, we’ve made significant progress bringing modern supplemental insurance to more Americans by teaming up with leading insurance carriers and benefits brokerage firms across the country,” said founder and CEO Veer Gidwaney in a statement. “This financing is an important step towards making health hardships less of a financial burden for Americans nationwide.”
Ansel highlighted its high net promoter score of 90 in 2023 in its latest announcement, attributing the rating to its new claims automation service that allows members to receive benefits without filing a claim.
Ricky Lai, a partner at Portage, in a statement said he finds confidence with Ansel's approach because of nationwide growth in high-deductible health plans.
Other groups participating in funding included Two Sigma Ventures, Brewer Lane Ventures and Morgan Creek Capital Management.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.